Ramucirumab
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Ramucirumab |
| DrugBank ID | DB05578 |
| KG Predictions | 20 |
| DL Predictions (≥0.7) | 750 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 20 knowledge graph predictions and 750 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| lung cancer | KG |
| non-small cell lung carcinoma (disease) | KG |
| gastric adenocarcinoma | KG |
| squamous cell carcinoma of liver and intrahepatic biliary tract | KG |
| hepatocellular carcinoma | KG |
| pediatric hepatocellular carcinoma | KG |
| fibrolamellar hepatocellular carcinoma | KG |
| adenocarcinoma of liver and intrahepatic biliary tract | KG |
| undifferentiated carcinoma of liver and intrahepatic biliary tract | KG |
| liver cancer | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB05578
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.